Clinical Trial: A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923357) titled 'A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus' on Nov. 02.

Brief Summary: This study is a multicenter, randomized, double-blind (with open-lable semaglutide 1.0 mg, active comparator), placebo-and active-controlled, parallel-group Phase 2 clinical trial aimed at evaluating the efficacy, safety and pharmacokinetic (PK) characteristics of SAL0150 tablets in subjects with Type 2 Diabetes Mellitus (T2DM) who have inadequate glycemic control after diet and exercise alone or after diet and exercise combined with stable-dose metformin monotherapy.

Study S...